File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Spatiotemporal Delivery of pBMP2 and pVEGF by a Core-Sheath Structured Fiber-Hydrogel Gene-activated Matrix Loaded with Peptide-modified Nanoparticles for Critical-sized Bone Defect Repair

TitleSpatiotemporal Delivery of pBMP2 and pVEGF by a Core-Sheath Structured Fiber-Hydrogel Gene-activated Matrix Loaded with Peptide-modified Nanoparticles for Critical-sized Bone Defect Repair
Authors
Keywordsbone regeneration
composite scaffolds
gene delivery
gene-activated matrix
spatiotemporal
Issue Date1-Nov-2022
PublisherWiley
Citation
Advanced Healthcare Materials, 2022, v. 11, n. 21 How to Cite?
Abstract

The clinical translation of bioactive scaffolds for the treatment of large segmental bone defects remains a grand challenge. The gene-activated matrix (GAM) combining gene therapy and tissue engineering scaffold offers a promising strategy for the restoration of structure and function of damaged or dysfunctional tissues. Herein, a gene-activated biomimetic composite scaffold consisting of an electrospun poly(epsilon-caprolactone) fiber sheath and an alginate hydrogel core which carried plasmid DNA encoding bone morphogenetic protein 2 (pBMP2) and vascular endothelial growth factor (pVEGF), respectively, is developed. A peptide-modified polymeric nanocarrier with low cytotoxicity and high efficiency serves as the nonviral DNA delivery vector. The obtained GAM allows spatiotemporal release of pVEGF and pBMP2 and promotes osteogenic differentiation of preosteoblasts in vitro. In vivo evaluation using a critical-sized segmental femoral defect model in rats shows that the dual gene delivery system can significantly accelerate bone healing by activating angiogenesis and osteogenesis. These findings demonstrate the effectiveness of the developed dual gene-activated core-sheath structured fiber-hydrogel composite scaffold for critical-sized bone defect regeneration and the potential of cell-free scaffold-based gene therapy for tissue engineering.


Persistent Identifierhttp://hdl.handle.net/10722/332025
ISSN
2023 Impact Factor: 10.0
2023 SCImago Journal Rankings: 2.337
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHe, S-
dc.contributor.authorFang, J-
dc.contributor.authorZhong, CX-
dc.contributor.authorWang, M-
dc.contributor.authorRen, FZ-
dc.date.accessioned2023-09-28T05:00:21Z-
dc.date.available2023-09-28T05:00:21Z-
dc.date.issued2022-11-01-
dc.identifier.citationAdvanced Healthcare Materials, 2022, v. 11, n. 21-
dc.identifier.issn2192-2640-
dc.identifier.urihttp://hdl.handle.net/10722/332025-
dc.description.abstract<p>The clinical translation of bioactive scaffolds for the treatment of large segmental bone defects remains a grand challenge. The gene-activated matrix (GAM) combining gene therapy and tissue engineering scaffold offers a promising strategy for the restoration of structure and function of damaged or dysfunctional tissues. Herein, a gene-activated biomimetic composite scaffold consisting of an electrospun poly(epsilon-caprolactone) fiber sheath and an alginate hydrogel core which carried plasmid DNA encoding bone morphogenetic protein 2 (pBMP2) and vascular endothelial growth factor (pVEGF), respectively, is developed. A peptide-modified polymeric nanocarrier with low cytotoxicity and high efficiency serves as the nonviral DNA delivery vector. The obtained GAM allows spatiotemporal release of pVEGF and pBMP2 and promotes osteogenic differentiation of preosteoblasts in vitro. In vivo evaluation using a critical-sized segmental femoral defect model in rats shows that the dual gene delivery system can significantly accelerate bone healing by activating angiogenesis and osteogenesis. These findings demonstrate the effectiveness of the developed dual gene-activated core-sheath structured fiber-hydrogel composite scaffold for critical-sized bone defect regeneration and the potential of cell-free scaffold-based gene therapy for tissue engineering.<br></p>-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofAdvanced Healthcare Materials-
dc.subjectbone regeneration-
dc.subjectcomposite scaffolds-
dc.subjectgene delivery-
dc.subjectgene-activated matrix-
dc.subjectspatiotemporal-
dc.titleSpatiotemporal Delivery of pBMP2 and pVEGF by a Core-Sheath Structured Fiber-Hydrogel Gene-activated Matrix Loaded with Peptide-modified Nanoparticles for Critical-sized Bone Defect Repair-
dc.typeArticle-
dc.identifier.doi10.1002/adhm.202201096-
dc.identifier.scopuseid_2-s2.0-85136879920-
dc.identifier.volume11-
dc.identifier.issue21-
dc.identifier.eissn2192-2659-
dc.identifier.isiWOS:000846477600001-
dc.identifier.issnl2192-2640-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats